| Part I: One Man's Trash Is Another Man's Treasure - MedClean Technologies (OTC:MCLN) | | Print | |
| Written by M.E.Garza | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Tuesday, 01 December 2009 07:26 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
 Let's start with the worst kept secret on the Internet. Yesterday, our subscribers were issued a trade alert about this week's profiled company, MedClean Technologies (OTC:MCLN).
The company enables hospitals and other medical facilities to treat and dispose of their regulated medical waste and provide HIPAA-compliant destruction of confidential documents in an efficient, compliant, safe and cost-effective manner. If you haven't seen the video of their state-of-the-art on-site treatment system, please take a look at it on the right before reading further.
Prices gapped up significantly as the market prepared to open and as the echo of the opening bell faded, the strength of the stock grew in not only momentum and incredible volume, but price as well. It started out like many of our other profiled picks- reaching a morning high of nearly eight cents- almost double where it had closed on Friday, but instead of trading out before the "overbought" equity turned, investors held on as the price polarity shifted. At the end of the day, according to many of the angry e-mails and messages that were passed along, our "over-hyped pick was pure garbage." As writers who cover the sector, some claim that we can control many things, but two of the things we definitely can't control are the buy and sell buttons of our readers. If we could, perhaps there would be more winners than losers among us, but then again we must remember that it's called a trade and almost by definition, someone will always walk away more happy than another. In the market, someone always holds longer than they could have and someone always sells before they should have. Was Monday's incredible trading action that saw over a quarter of a billion shares change hands garbage or greed? If you were one of the ones who feels you got caught holding the bag, then the answer may seem obvious- yet the matter is definitely quite debatable. Some hands, without question, were even shaken out of their shares by fear of a mad rush to cash out huge profits. Amazingly, Monday's scoreboard showed that the stock closed mere fractions of a cent from where it closed on Friday's previous market session (-$.0073), but in the world of pennies, even the slightest percentages losses can quickly add up. We understand that in today's market, most investors are in for a quick buck. These days, the impatient investor is more common that anyone would like to acknowledge in the biotech sector- a sector that had historically been home to some of the most patient investors on the street. At the end of the day, the score card shows something else, however. Some among you, who had been holding shares since they were priced at tenths of a cent made their money and moved on with big smiles on their face. They're in for a very merry holiday season, it would seem. Others, added even more shares to their portfolio on today's dip and smiled into the evening sunset. Self included. Why, after all, should they sell their significantly vast amounts of MCLN shares at a vastly undervalued six, seven, or even eight cents? As I mentioned in my alert to subscribers, this is a stock that just emerged from sub-penny levels, yet to some it may come as a shock that I continue to stand firmly behind my estimated short term value target of $.40 per share. "You've lost all credibility," writes another. Maybe so, but those of us who carefully researched this company, spoke to their management group at length and looked carefully through their books and track record still feel not only bullish about this company, but extremely so. If this were a glorified pump and dump scheme, then there are many of us who are still enthusiastically waiting to for the perfect opportunity to dump- and that is more along the lines of driven, calculated investing, we think. Maybe we have lost our marbles, but the fact that paid subscribers feel compelled to share our picks is a two sided issue that we are wrestling with. On the one hand, if the information were worthless, then no one would care or even give the shortsighted and simple-minded actions a second thought. On the other, that brings me- in my own long winded way- to tell you about MCLN. This is rare penny level OTC entity that, we can assure you, is a real company, selling a real product, with real value and income, run by a real management team with tremendous experience that are all working hard together to fulfill real orders and contracts in a sector of the market still looking for a real leader to meet a pent up demand. "Most of our competitors are mom and pop type shops," says Scott Grisanti who recently transitioned from CEO to Chairman of the Board of Directors for MedClean. Even more compelling is the fact that this sub-sector (regulated medical waste) features companies whose market cap and trade values are most often based not on three or four times trailing twelve months (TTM) revenue and earnings, but actually fourteen to twenty five times those figures! See sector leader Stericycle, Inc. (NASDAQ:SRCL) for a high mark example of that valuation analysis. SRCL's shares trade at over $54 per share. On the low end, you may want to examine Sharps Compliance Corp. (OTC:SMED) whose shares trade at over $9 per share. Are you understanding the undervalued message yet? If you control a million shares or more of this company, you are in very good company. This isn't the bottom of the final inning with two strikes and two outs. This ballgame is just getting started. Pitch number one just zoomed by. For some it became a home run. For others things are just getting warmed up. The MedClean story, itself, gets better. Through a recently announced partnership with the privately held Vestara, the Irvine, CA based provider of technology to automatically identify, sort, and segregate hazardous and non-hazardous pharmaceutical waste into proper streams, MedClean Technologies is showing some tells that they may be looking to establish a strong presence in the equally lucrative and under-served pharmaceutical waste management sector as well. Already MedClean's solutions provide significant advantages for hospital customers compared to other approaches. These include lower costs, reduced risk and protection of host communities and overall better environmental solutions. A single MedClean Container system can treat 1 million pounds of regulated medical waste per year, in addition to handling confidential document destruction (such as medical records), with a smaller footprint compared to multiple vendors handling different tasks for a hospital. As one might imagine, the sales and orders for these cost, time and money saving systems are piling up. Earlier this year in fact, MedAssets, Inc. (NASDAQ: MDAS), the $23 per share company whose group purchasing organization partners with hospitals and health systems to help improve quality and lower costs within the U.S. healthcare system awarded a contract to this penny stock company, and while specific financial details of the lucrative contract have yet to be completely revealed, it's safe to assume that the contract has enhanced the company's financial strength. After all, MedAssets runs one of the nation's largest group purchasing organizations (GPOs) and it helps to facilitate not only sales but leases of the equipment. "Our manufacturing and installation bandwidth is running at full capacity," says David Laky, President and Chief Executive Officer of the company, "but that's a nice problem to have and we're actively making changes to accommodate more orders." "We're excited about the collaboration with MedAssets and they have definitely enabled us to provide our solutions to an expanding base of customers,” adds Chairman Grisanti. The leaders appear particularly proud that their system meets the stringent and rigorous requirements of MedAssets as well as the tough regulatory requirements for processing medical waste in many states, including New Jersey- where customers in both the pharmaceutical and medical fields are required to minimize liability and protect the environment more strictly than just about any other state in the country. In May, following a joint authorization issued by the state Department of Environmental Protection and Department of Health and Senior Services, MedClean was approved to provide New Jersey state hospitals with their systems following one of the most rigorous review processes and the first such approval for an on-site hospital system granted since 2005. This was yet another in a series of victories for the group since their official launch of the company’s integrated business plan to emerge as the leader in the 2 billion market while transforming themselves into MedClean Technologies from their previously named Aduromed brand. As part of that transformation, earlier this month, the company announced a restructuring of their management team. Laky was promoted to President and CEO as Grisanti transitioned to Chairman of the Board. Joseph Esposito, a key figure and accomplished leader of the group and MedClean's past Chairman, remains on the board as a director and continues to serve as a consultant to the Company. Since that time, the company went from posting a loss of $7.8 million in 2008 to becoming cash flow positive on an EBIDTA basis in the 3rd quarter of 2009- marking impressive Third Quarter Revenue Increases 108% Year-Over-Year. Tomorrow, in part two of our special report on the company, we're going to dive much further into our conversation with the unique management team- who actually share ties from their days at eResearchTechnology, Inc (Nasdaq:ERES). During their tenure there, the company's market valuation grew from $27 million to a peak of $1.5 billion, receiving recognition from Fortune Magazine as the number two fastest growing company in America and helping the company become the industry leader in safety drug research for biopharmaceutical, Contract Research Organizations (CROs) and medical device companies. In the meantime, let's take a closer look at yesterday's trading action. At first glance, it appears that the parabolic moves in share price for the stock may have signaled the end of the trend, but we have not really seen a verifiable sharp reversal in direction here. Every stock has to breathe and there is no doubt that share prices which rise faster and faster can not sustain that sharp upward rise, since profits are being made very quickly and must be at some point taken. The jury, in fact, is still out and how quickly this stock will grow another set of legs to take it up further and will become more clear by the end of today's session, it may even become quite clear in the first thirty minutes of trading. Fundamentally, the stock is very sound. Technically, we leave you with two different looks at the chart analysis. Click here to study the first one and here to view the second. Remember also that MCLN has been on the SEC's Regulation SHO compliance tool list for over 20 consecutive days and is now high on the market maker's "buyin imminent" list. In our opinion, continued volume will finally force the market makers to cover and help fuel prices as demand exceeds supply. See this link for more information: http://www.buyins.net/tools/short_list.php?dys=%3E12 As always, we urge you to do your own research and wish you only the best in your trading and investing. Batter up! Disclosure: Long MCLN BiomedReports is not paid or compensated to report news and developments about publicly traded companies. Full disclosure can be read at the bottom of / About Us / Section Add this page to your favorite Social Bookmarking websites           
Set as favorite
Bookmark
Email this
Trackback(0)
Comments (39)
Jane Gregory
said:
|
TrackBack URI for this entry
Subscribe to this comment's feed|
... Thanks for the brilliantly explanation of yesterday's price action in MCLN. Enjoyed the humor in your writing but yet you backed it with facts. Appreciate you taking the time to provide your subscribers with such detail and informative information. |
|
Ubor
said:
|
... Your candor is refreshing. However, you underestimate others you have shared the pick with earlier than subscribers, such as StocksHaven and your own position which drove up the price just prior to sharing the pick with subscribers. With large pre-pick volume shared through his network of 'VIP's' and your own position and whoever anyone else's VIP's are, by the time subscribers start buying, there's many who are looking to leave. One thing you could do that would help is declare your shares or if you sold any yesterday, because it's clear that some who knew to buy before Monday under .02, were just as ready to sell at 150-200% profit and not 'risk' holding any longer. |
|
David Gunning
said:
|
... Outstanding article. I, for one, look for high quality research, and not some garbage newsletter. For all of you who are looking for a quick buck, maybe you should join explicitpicks or monsterstox for free, and leave this PAY site to the professionals. |
|
Julian
said:
|
... In response that subscribers posted your trade alert on message boards, why did you post 'the next Biel-like tradew on tap..' on the non-subscriber content section of BioMed Reports? Perhaps it should have been posted initially on the subscriber only section first? |
|
Robert
said:
|
... Look at it this way...there were a lot of weak hands leaving yesterday. The road higher should not be as steep. |
|
Deolall Itwaru
said:
|
... In response to Ubor. It would be foolish for Garza to declare his shares. The reason being, he said it in his article, this is only trading. The first rule of investing is never to miss taking a profit. Second rule is do your own dd. I am sure that the original article did in fact remind us to do our own dd. I once read a quote from someone who said, 'taking profit is fine even if it is early.' He went on to say 'Have you ever seen someone with losses in the deposit line at the bank?' That said, it would be foolish for Garza not to take a profit. What is smart, is as he said, he re-invested on the dips. That is conviction of principle to me. The idiots who shared this information on bulletin boards etc. are the ones to blame for any losses. I think it is unfair to vent on BMR. It is easy to blame Garza, because he is the one standing in front of you. It is not easy to blame the JERK who posted on the bulletin boards because you have no idea who he/she is. But take another look at the guy standing in front of you, he is loaded with shares just like you and I for the long run. Thank you Garza. |
|
dwight vaughn
said:
|
... Great write up. I also understand where you are coming from regards all the subscribers posting on forums. We pay for your analysis, recieving in return some insight on companies with a chance to move higer based on valuation. These idiots that run around posting on other forums about biomed reports effectively hung themselves. Next time keep it to yourself and let the stock rise on its own merits. |
|
Jason
said:
|
... I placed and order yesterday for the closing price on Friday and walked away from the computer. I came back late in the afternoon and noticed my order had been filled and the PPS still dropping. I do know that if this had been emailed to subscribers before any post on the biomeds page, the subscribers might had been able to get in around the .02's early on Monday before any info had been reliesed to the public. Im curious how many people got screwed yesterday because some subscribers decided to take this info and post it on the message boards? |
|
marc tino
said:
|
... ON MY MARKET DEPTH IT SAID THE LOW FOR YESTERDAY WAS .005 AN THE HIGH WAS .076 WHEN IT CLOSED AT LIKE.034 ON FRIDAY...WHAT SCARED ME IS THAT IS DROPED TO ALMOST NOTHING YESTERDAY AN NOW ON ITS OPEN TODAY NOT MUCH OF A MOVE... |
|
biotrader
said:
|
... Racing to zero. Nothing is ever the "next" anything. When stocks make bog moves they usually do it with no fanfare and very quiet Yahoo message boards. |
|
Robert
said:
|
... Whut happened wuz.... 5 days of price jumps, taking a high volume of shareholders holding massive amounts of shares bought sub-penny up to multiples + spike yesterday sent them all to the sell side + panic as the price dropped and all old shareholders jumped to sell their multiples + extremely high number of shares = disaster. Anyway, this company has two choices only...go bankrupt or sell another half billion shares. They can't even finish an install, and have had orders since 2008 they have not even started to work on. They may have a backlog, but they have proved they cannot handle it. The "profit" this past quarter came from supplying two older systems, and the "contract" they just signed is, in my opinion, a contract that allows them to sell to the health care facilities in the purchasing group. I do not believe there have been any money producing contracts signed yet, and even if there were the company could not fill the orders. I do not expect this post to see the light of day, but maybe BioMed can learn something from this fiasco. I hope does not stop giving out potential good companies because of this. No one can pick all winners, not even BioMed. I look forward to another greater pick. |
|
REB
said:
|
... Just one detail. I agree with Ubor above that it would be appropriate for the subscribers to know what is the position of the principals of this newsletter/site in the stock they are producing the research on. If BiomedReports clearly frontruns its subscribers and sells the position just after their 'alert', it is not very different from the usual "pump and dump". The leaks to the outside world, in this scenario, are actually good for Biomed principals (although they are clearly bad for subscribers) as volume and price increases much more if everybody knows, rather than just the subscribers (which is fabulous for a quick exit) I presume that under these circumstances it will be quite difficult to maintain subscribers in the long run. Having said the above, I don't necessarily have a problem with them buying before the announcement and then taking profits after it. It is up to each one to decide if they want to play and are able to make money under those conditions. What I do have an issue with is that the disclosure (at least for the subscribers) should not just be "long the stock" at the end of a piece promoting the 'long term' fundamental value in the name. It does not really look like full/accurate disclosure. In any case, it is clear that each one has to assess what is the value of the alerts in terms of P&L. Rgds |
|
David Gunning
said:
|
... The support line of .031 is being confirmed again today. Hang on to this one folks! |
|
Shannon
said:
|
... Disregard my previous comment. I was looking at the wrong sec filings. MCLN actually had positive cash flow this last quarter. While not enough to push this past the pennies, it's a positive step. Again I ended up looking at the wrong company, but do your DD and buy at your own risk. Please disregard my previous comment again. Thanks Shannon |
|
Krunchy
said:
|
... In my opinion Garza is a hero and reporting on the best stocks with a tremendous amount of research. If you are smart you should buy MCLN while the price is below .05 because this is going to go above .10 in no time. It is the fools on the financial boards who have been hit the hardest. I think it's time for everyone to realize that the financial boards are filled with nothing but spam and to never follow them. Join BMR and you will be rewarded. |
|
jassie
said:
|
... I agree also that some people post the news in diffrent forums once they see it in subscribers only section and others like me lose becuase of it. The best way to make sure that all the paid subscribers get information about new picks at same time is that you should first post a link that new pick will be announced at particular time of day and the market should be open at that time and then later on annouce the pick at that time in subscriber only section at that time so that all the paid subscribers can see it togeather and place there orders as the market will be open at that time before the news is spread by some on diffrent forums. This is the best way i can think of to make sure all the paid subscribers get information at same time. If i am not wrong then the information about MCLN was released before the market opened and by that time the news was all over diffrent forums. |
|
REB
said:
|
... Hey guys, what happened with my comment? Not good enough for this forum? I have to say that is reason for concern. Would appreciate if you could let me know what is going on. Thanks and rgds |
|
James Burns
said:
|
... Subscribers who post BioMed alerts on other boards are truly idiots, but I suspect yesterday's action was primarily a naked short attack which is very common with penny stocks, when the short sharks are done playing around the stock will trade more in line with fundamentals which is a mixed bag: profitable, cash flow positive penny stock (rare), but a very high share count and needing to raise more capital. |
|
Pitt4Rx
said:
|
... While it is nice to defend the stock pick and pump and dump; it was obvious others knew before subscribers when on Friday the buying began with the 100% rise and then the sell into the panic buying on Monday. Subscribers should be told picks in advance of non-subscribers; however this was like a sabotage against subscribers knowing fully the effect of the supposed "insider" information out on Sat or Sun after an initial huge buying frenzy on Friday by "who" I avoided this because I saw that 100% gain on Friday which showed it was leaked out beforehand. I agree with UBOR on this one |
|
Robert Renders
said:
|
... I personally believe a hero would include Q10 fine print such as: To supplement its cash resources, the Company has been pursuing a number of alternative financing arrangements with various investment entities. We are currently looking to secure additional working capital to provide the necessary funds for us to execute our business plan through various sources, including bank facilities, bridge loans and equity offerings. However, we continue to incur significant operating losses and the resultant reduction of our cash position. We cannot assure that we will be able to obtain additional funding, and the lack thereof would have a material adverse impact on our business. Moreover, any equity funding could be substantially dilutive to existing stockholders. The aforementioned factors raise substantial doubt about our ability to continue as a going concern. In the event the Company is unable to continue as a going concern it may pursue a number of different options, including, but not limited to, filing for protection under the federal bankruptcy code. |
|
REB
said:
|
... Dear Mr. Garza, No intention of being obnoxious, I just need to understand. By the way, I am taking the time as I am a paying subscriber and I am holding some of MCLN. I thought it was a blip, but it seems that the only comments allowed in this site are the ones calling you 'brilliant', 'hero', 'maestro' and the like. It looks more Hollywood than a serious and independent research and investment site (which is what I was looking for). I think my comment was quite fair in the sense that, if you are not going to make a more transparent disclosure to your subscribers in relation to your positions and time horizon of your calls, this site does look (to any reasonable mind) like any other "pump and dump" joint. It is also difficult to believe that you will make a serious effort to bring the leaks under control when, in this situation, they are in your absolute interest (and in the detriment of your subscribers). Subscribers, like myself, who would like to believe that your research is really independent and accurate, including the time horizon related to the potential trades. May I insist that time horizons related to trades are key, as you very well know, especially if you are selling all or most of your previously acquired position immediately after you break the “news” (while suggesting it is a longer term trade). Case in point MCLN: anybody reading your piece would have had the impression that you believed it was a longer term trade on the back of ‘fundamental factors’. If you first buy, then issue a buy recommendation to your subscribers (that “mysteriously” and consistently leaks), and then sell on your own news while not disclosing that to your subscribers, it is pretty clear that your site is not different from any other “pump and dump”. Or maybe a twisted variation of the “front-running” gig, where you not only buy before your clients but also turn around and sell while pretending you are long (how much, 1 share? Or is it 2?). I repeat what I mentioned before, I really don’t care if it is right or wrong, I just think that if you want to charge a subscription, you will have to make an appropriate disclosure. The simple truth is that you cannot have it both ways, i.e., present yourself as an independent, serious and factual research and investment firm and at the same time front-run your clients and dump the stock at the same time you recommend to buy. It is either getting people to pay the subscription based on how much they value your research or screwing people for as long as they take to find out that your research is not more than another crooked operation. As I said, I am new to the site and in some respects I find it useful. I am also testing the waters in terms of the alerts and, so far, I am not impressed. This is important as I am not paying a subscription to learn, but to get information that can be monetized through trading (and I am sure that is the case for many). I am neither looking to get comments published on your site, I don’t care. If I wanted to do that I could just air my opinion in any of the free message boards available that so keenly follow your 'research' (including the leaks). My ONLY point, having paid for your service, is understanding WHICH ARE THE RULES OF THE GAME, what is the deal. A mute response would obviously point to the fact that the only rule is that you are out to screw your subscribers. I will very much appreciate an answer at your earliest convenience. You have my e-mail. Regards, |
|
hal uy
said:
|
... I wish these subscriber alerts were posted during market hours. premarket or post market the market makers make a killing |
|
sumesh
said:
|
... I agree with Mr. Garza. I do know technical analysis and yesterday after looking at the chart, I advised most of my members to not buy into it but put it on watchlist and wait for retracement as stock was quite high and it has gained a lot in past 30-days. As part of my investing rules, I never chase, and if I am tempted, I get my feet wet with say 10% or 20% position and then average down on every 25% drop. Lets not blame Garza, blame yourselves if you dont know when to enter. I entered BIEL at 0.008 and never complained. I entered PWRM at 0.031 and IMGG at 0.125. Sometimes things dont go as planned, this is why you buy in blocks and not in bulk. |
|
dante
said:
|
... Seems like Mr Garza picks and choses the comments to be posted. That is a little bit arbitrary but consistent with the credibility of biomedreports. I had posted a comment that I would like to see posted. |
|
Dhakshinamoorthy Subramani
said:
|
... Very good article. Thanks for the details. Only issue is, you should not have posted the "the next Biel- like trade on tap" under the non-subscriber section on BioMed reports. Immediately the name of MCLN was all over in internet and the price got hooked up. It should have been posted only on the subscriber only section first. Also, the name of the stock should be revelaed only at 9:30 AM so that subscribers can benefit before the non subscribers. Thanks. |
|
Ranadheer Kakloor
said:
|
... I wonder why the company didn't buy back some of its shares when it was trading at half a cent. Should have done my own DD. |
|
cihan
said:
|
... Let's be honest with each other folks! No one expected Garza not to be in on the action prior to the special report on Sunday...this stock moved from half a penny to 4 cents on friday - couple days before BMR article-. What pissed off a lot of people, is that the articles are published on late sundays, which allows the word to spread. You can blame it on people on message boards for sharing the news, but keep in mind one thing: If you had stocks of a company at sub-penny levels, and found out BMR was issuing a special report, would you not try to spread the word? This is inevitable. However, if these alerts are issued during the day, then members would receive an email before the word is spread, and have the upper hand. When a special report is issued 10 hours before the bell, it is not special anymore! On the other hand, if an alert is sent via email to members, we would have the advantage to buy in before others, and enjoy the benefits of being a paying member...If BMR will continue issuing special reports, they have to make sure that members benefit more from these reports than others...Otherwise, I can see many people not renewing their memberships when the time comes as a result of this wide-spread frustration... Hope Garza and others pay heed to this suggestion, and do the right thing. |
|
M.E.Garza
said:
|
... Thank you all for your comments and support. Anyone who really knows me knows that our readers and subscribers are the most important element of our news site to me. I want to see everyone succeed and make lots of money. If it makes you feel any better, I am STILL holding a substantial number of shares in MCLN. I refuse to sell them at a discounted price. The consolidation and price action is very healthy. Next leg up is coming soon. This is a very healthy company with a great product that is much needed by their customer base. Good luck to all and never hesitate to e-mail me. |
|
roy cordero
said:
|
... I really got caught off gaurd with this stock. I have had other stocks that have been reccomended on this site that has worked out well. I had a buy order in on mcln on monday and my account is through tdameritrade, i had the order in since market open the problem i had is my order was not filled until 10:15 i was on the ith tdameritrade trying to figure out why. The explained to me unlike regular stocks which is first come first serve, penny stocks have no rules and something really quirky was happening. While i was on the phone with tdameritrade the order finally got filled. I was in at .062 and i had made 1k, the problem is that lasted for maybe 2 minutes after it took me 45 minutes for my trade to execute. Then there was a hug dump and continues to be. Now i'm down $2575 an i'm stuck. Mike do you still feel based on technicals that the price will go to .40 cents? |
|
Bogers
said:
|
... I took out a subscription to BioMed Reports ($ 120.-and no refundable trial period) and was one of the first (??) to read Garza's report on MCLN. At that MCLN shares were 5.8 cents and rising fast. I bought some at 6 c. At the close MCLN had dropped back to about 3 cents. Lost half of the investment, which was a damm lot more than the $ 120 I paid for write up. Although BioMed declared that only subscribers would get the details of the MCLN recommendation, he was all over the internet (like Garza's halleluja article. Inspite of all the good news at MCLN) the stock dropped some more the next day. I know I did it all wrong,but I sure wish I had never set eyes on the BioMed recommendation. For starters, it would have saved me $ 120 for starters to qualify for being first to hear about this eh..promising investment. You live and learn... |
|
REB
said:
|
... Thanks a lot for publishing my two comments (although the second one was more intended to Mr. Garza rather than the world, but that is fine). I think that speaks loudly of your willingness to be straightforward with your subscribers. One final question: any short term catalyst for MCLN that you know? Thanks a lot again and best rgds, |
|
Robert
said:
|
... I have no doubt about Garza's sincerity, and desire to make BMR a respected web site designed to help investors. However, MCLN is a bad pick, and is destined to either go bankrupt or be further painfully diluted. It will be sub-penny again in less than 20 trading days. |
|
David Bauman
said:
|
... I agree wholeheartedly with REB's analysis and critique of biomed. I hope you make some changes which inspire subscriber confidence. Otherwise, what goes around, comes around. It seems appropriate to publish all comments rather than screening them. That would also inspire more confidence in your readers and act as a self-editing mechanism to keep the comments to the point and appropriate. |
|
robert campi
said:
|
... Form 4 just filed. Manatuck Hill Partners exercized warrants for 30 mil shares at almost no cost and sold them plus another 30 mil or so. They still have about 100 mil but the prices they sold doesnt instill much confidence; price ranged from .0419 to .0266 on dates 11/30 to today. |
|
JonMK
said:
|
... I created a blog to piece together all of the pertinent information regarding this gold mine. If interested, please click on http://medcleantechnologies.blogspot.com/ All the best |
|
Write comment
